DePuy Synthes receives FDA 510(k) clearance for reverse shoulder arthroplasty system
Click Here to Manage Email Alerts
DePuy Synthes has announced FDA 510(k) clearance for the Inhance shoulder system for use in reverse total shoulder arthroplasty procedures, according to a press release.
The Inhance system, which previously received FDA 510(k) clearance for use in anatomic shoulder arthroplasty procedures, is designed for use in hospitals, outpatient settings and ASCs. The system allows surgeons the intraoperative flexibility to change their approach based on humeral bone quality, glenoid bone loss or rotator cuff deficiency, according to the release.
“Adding the reverse total shoulder arthroplasty to our Inhance shoulder system is helping us transform patient care,” Rajit Kamal, worldwide president of sports medicine and shoulder reconstruction at DePuy Synthes, said in the release. “This reinforces our commitment to innovation that addresses the most pressing needs of surgeons today and the market dynamics driving clinical trends of tomorrow,” Kamal added.
Read more about
Click Here to Manage Email Alerts